Suppr超能文献

增量式和非频繁血液透析:透析起始和保守治疗的新范例

Incremental and infrequent hemodialysis: a new paradigm for both dialysis initiation and conservative management.

作者信息

Rhee Connie M, Ghahremani-Ghajar Mehrdad, Obi Yoshitsugu, Kalantar-Zadeh Kamyar

机构信息

Division of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, CA, USA -

Division of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, CA, USA.

出版信息

Panminerva Med. 2017 Jun;59(2):188-196. doi: 10.23736/S0031-0808.17.03299-2. Epub 2017 Jan 13.

Abstract

Registry or national dialysis data show that a sizeable proportion of contemporary dialysis patients have substantial levels of residual kidney function especially upon transitioning to dialysis therapy. However, among incident hemodialysis patients, the prevailing paradigm has been to initiate "full-dose" triweekly treatment schedules irrespective of native kidney function in most developed countries. Recognizing the benefits of residual kidney function upon the health and survival of dialysis patients, there has been growing interest in incremental hemodialysis, in which dialysis frequency and dose are tailored according to the degree of patients' residual kidney function. Infrequent hemodialysis can also be used for those who prefer a more conservative approach in managing uremia. Clinical practice guidelines support the use of twice-weekly hemodialysis among patients with adequate residual kidney function (renal urea clearance >3 mL/min/1.73 m2), and a growing body of evidence indicates that incremental hemodialysis is associated with better preservation of residual kidney function without adversely impacting survival. Nonetheless, incremental hemodialysis remains an underutilized approach in this population. In this review, we will discuss the history of the twice- versus triweekly hemodialysis schedules; current clinical practice guidelines regarding infrequent hemodialysis; emerging data on incremental treatment regimens and outcomes; and guidelines for the practical implementation of incremental and infrequent hemodialysis in the clinical setting.

摘要

登记处或国家透析数据显示,相当一部分当代透析患者具有相当程度的残余肾功能,尤其是在开始透析治疗时。然而,在大多数发达国家,对于新接受血液透析的患者,普遍的模式是不管其自身肾功能如何,都开始采用每周三次的“全剂量”治疗方案。认识到残余肾功能对透析患者健康和生存的益处,人们对递增式血液透析的兴趣日益浓厚,即在递增式血液透析中,透析频率和剂量根据患者残余肾功能的程度进行调整。对于那些在管理尿毒症方面倾向于采用更保守方法的患者,也可采用不频繁的血液透析。临床实践指南支持在残余肾功能充足(肾尿素清除率>3 mL/min/1.73 m²)的患者中使用每周两次的血液透析,越来越多的证据表明,递增式血液透析与更好地保留残余肾功能相关,且不会对生存产生不利影响。尽管如此,递增式血液透析在这一人群中仍然是一种未得到充分利用的方法。在本综述中,我们将讨论每周两次与每周三次血液透析方案的历史;当前关于不频繁血液透析的临床实践指南;递增式治疗方案和结果的新数据;以及在临床环境中实际实施递增式和不频繁血液透析的指南。

相似文献

3
Infrequent dialysis: a new paradigm for hemodialysis initiation.非频繁透析:血液透析起始的新模式
Semin Dial. 2013 Nov-Dec;26(6):720-7. doi: 10.1111/sdi.12133. Epub 2013 Sep 9.

引用本文的文献

1
A practical approach to implementing incremental haemodialysis.实施递增血液透析的实用方法。
J Nephrol. 2024 Sep;37(7):1791-1799. doi: 10.1007/s40620-024-01939-2. Epub 2024 May 19.
3
Residual Urine Output and Mortality in a Prospective Hemodialysis Cohort.前瞻性血液透析队列中的残余尿量与死亡率
Kidney Int Rep. 2020 Feb 12;5(5):643-653. doi: 10.1016/j.ekir.2020.02.002. eCollection 2020 May.
5
Hyponatremia in the Dialysis Population.透析人群中的低钠血症
Kidney Int Rep. 2019 Mar 1;4(6):769-780. doi: 10.1016/j.ekir.2019.02.012. eCollection 2019 Jun.

本文引用的文献

6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验